FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

BSX

Boston ScientificNYSE · Health Care Equipment · Health Care
Previous close
43.91
Change
+0.04 / +0.09%
FinDog View
Bullish
52-Week Range
42.20 – 105.65
P/E (TTM)
17.3
Forward P/E
13.4
Based on consensus earnings for the next 12 months
Market Cap
$63.6B
1M
−14.62%
S&P 500 −2.41% over same period
Volume / Avg Volume
28.4M / 21.4M
1.33× average

Price History

Closing price · USD1M6M1Y5Y
4050607080FY26 Q2 EarningsFY26 Q1 Earnings2026-032026-052026-062026-082026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 19.51M6M1Y5Y
1718192021222026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-29$5.4B0.86 / 0.84−0.09%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-22$5.2B0.80 / 0.79+1.26%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-04—— / —+2.83%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-22—— / —−1.41%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-23—— / —−1.44%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-23$4.7B0.75 / —+2.24%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 0 of its 5-year rangeCheap
5-year range 19.3 – 86.8 · Median 65.3
No buybacks or dividends in the last four quarters
P/E (TTM)
17.3
P/B
2.6
P/S
3.0
PEG
0.38
Earnings Reaction
Over the last 6 reports, the stock moved ±1.5% on average on the first trading day after, rising 3 times
Most recent −0.09%
Volatility & Correlation
1-year beta 0.26 · Correlation with S&P 500 0.08Low beta
Annualized volatility 42% vs. 14% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 6 · $9.5MSell 0 · $0.00MNet buying $9.5M
  • 08-25Morano Susan EDirectorBuy$0.10M2,040 shares · Avg price 49.22
  • 08-05Habiger David CDirectorBuy$0.10M2,100 shares · Avg price 47.59
  • 08-04Habiger David CDirectorBuy$0.01M140 shares · Avg price 48.59
  • 08-03Mahoney Michael FChairman, President & CEOBuy$9.0M186,240 shares · Avg price 48.33
  • 08-03Habiger David CDirectorBuy$0.05M1,042 shares · Avg price 48.07
  • 07-31LUDWIG EDWARD JDirectorBuy$0.23M5,000 shares · Avg price 45.48
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q25.44+7.5%70.7%1.18—1.280.61
FY2026 Q15.20+11.6%69.4%1.10—0.170.90
FY2025 Q45.29+15.8%69.6%0.83—1.010.45
FY2025 Q35.07+20.3%69.9%1.05—1.160.51
FY2025 Q25.06+22.8%67.7%0.82—1.130.53
FY2025 Q14.66+20.9%68.8%0.92—0.350.45
FY2024 Q44.56+22.5%67.9%0.68—1.180.38
FY2024 Q34.21+19.3%68.8%0.73—0.820.32
FY2024 Q24.12+14.5%69.2%0.52—0.660.22
FY2024 Q13.86+13.8%68.6%0.68—-0.020.33
FY2023 Q43.73+14.9%69.2%0.58—0.690.34
FY2023 Q33.53+11.3%68.8%0.69—0.510.34

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
BSXBoston Scientific$63.6B17.3+7.5%70.7%−14.62%Bullish
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare